Rosin-based block copolymer intracellular delivery nanocarriers with reduction-responsive sheddable coronas for cancer therapy

2016 ◽  
Vol 7 (29) ◽  
pp. 4751-4760 ◽  
Author(s):  
So Young An ◽  
Sung Hwa Hong ◽  
Chuanbing Tang ◽  
Jung Kwon Oh

Rosin-based, reduction-responsive block copolymer-based nanocarriers exhibiting excellent colloidal stability enabling the delivery of anticancer drugs to cancerous tissues for the enhanced release of encapsulated drugs, offering great versatility as intracellular drug-delivery nanocarriers for cancer therapy.

Nanoscale ◽  
2015 ◽  
Vol 7 (34) ◽  
pp. 14191-14216 ◽  
Author(s):  
Seonmi Baek ◽  
Rajendra K. Singh ◽  
Dipesh Khanal ◽  
Kapil D. Patel ◽  
Eun-Jung Lee ◽  
...  

Effectiveness of the delivery of anticancer drugs and the efficacy of cancer therapy can be enhanced using smart multifunctional mesoporous nanoparticles.


2019 ◽  
Vol 10 (22) ◽  
pp. 2840-2853 ◽  
Author(s):  
Arman Moini Jazani ◽  
Newsha Arezi ◽  
Chaitra Shetty ◽  
Sung Hwa Hong ◽  
Haowen Li ◽  
...  

Dual acid/reduction-degradable block copolymer nanoassemblies both at core/corona interfaces and in micellar cores leading to synergistic and accelerated drug release for robust tumor-targeting intracellular drug delivery.


2009 ◽  
Vol 20 (6) ◽  
pp. 1095-1099 ◽  
Author(s):  
Ling-Yan Tang ◽  
Yu-Cai Wang ◽  
Yang Li ◽  
Jin-Zhi Du ◽  
Jun Wang

2007 ◽  
Vol 8 (6) ◽  
pp. 1966-1972 ◽  
Author(s):  
Simona Cerritelli ◽  
Diana Velluto ◽  
Jeffrey A. Hubbell

2007 ◽  
Vol 7 (12) ◽  
pp. 4612-4617 ◽  
Author(s):  
Franck Lacoeuille ◽  
Emmanuel Garcion ◽  
Jean-Pierre Benoit ◽  
Alf Lamprecht

As non-phagocytic eukaryotic cells can internalize particles <1 μm in size, small size (25 to 110 nm) lipid nanocapsules (LNC) are proposed for the intracellular drug delivery of anticancer drugs to cancer cells. LNC ofdifferent diameters were loaded with etoposide or paclitaxel and subsequently tested for drug release kinetics and their efficiency to reduce cancer cell growth in cell culture. Relative high drug loads could be achieved and sustained drug release can be provided over a period ofseveral days (etoposide) up to a few weeks (paclitaxel). While particle size exhibited only minor influences on the release kinetics, higher initial drug load led to a distinctly lower burst release. In a cancer cell culture model, etoposide or paclitaxel LNC showed a 4-fold or 40-fold higher efficiency, respectively than the drug solution while blank LNC were found to be less toxic than the pure drug at equivalent concentrations. The uptake and intracellular accumulation ofLNC was confirmed by confocal laser scanning microscopy after fluorescence labeling of the nanocarriers. This nanoparticulate system is able to achieve efficient intracellular drug concentrations and seems to be therefore a promising therapeutic approach in cancer treatment.


Sign in / Sign up

Export Citation Format

Share Document